Ubs Group Ag Neovasc Inc Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$15.81 - $29.88 $11,636 - $21,991	-736 Reduced 55.51%	590 $17,000
Q4 2022 Feb 08, 2023	BUY	$6.5 - $16.05 $4,082 - $10,079	628 Added 89.97%	1,326 $20,000
Q3 2022 Nov 10, 2022	SELL	$5.95 - $7.93 $13,494 - $17,985	-2,268 Reduced 76.47%	698 $5,000
Q2 2022 Aug 10, 2022	BUY	$4.9 - $10.75 $14,533 - $31,884	2,966 New	2,966 $18,000

Ticker NVCN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 2,743,140
Description
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly kn...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.